DZHK Deutsches Zentrum für Herz-Kreislauf-Forschung e. V. Revenue and Competitors
Employee Data
- DZHK Deutsches Zentrum für Herz-Kreislauf-Forschung e. V. has 59 Employees.
- DZHK Deutsches Zentrum für Herz-Kreislauf-Forschung e. V. grew their employee count by 18% last year.
DZHK Deutsches Zentrum für Herz-Kreislauf-Forschung e. V.'s People
Name | Title | Email/Phone |
---|
DZHK Deutsches Zentrum für Herz-Kreislauf-Forschung e. V. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 38 | 31% | N/A | N/A |
#2 | N/A | 201 | 28% | N/A | N/A |
#3 | N/A | 71 | 34% | N/A | N/A |
#4 | N/A | 65 | 27% | N/A | N/A |
#5 | N/A | 134 | 26% | N/A | N/A |
#6 | N/A | 38 | 36% | N/A | N/A |
#7 | N/A | 36 | 29% | N/A | N/A |
#8 | N/A | 28 | 33% | N/A | N/A |
#9 | N/A | 38 | 36% | N/A | N/A |
#10 | N/A | 29 | 480% | N/A | N/A |
What Is DZHK Deutsches Zentrum für Herz-Kreislauf-Forschung e. V.?
**Joining Forces to Fight Heart Disease**\n\nScientists from 31 institutions all over Germany. One goal: to advance not only treatments but also diagnosis and prevention of cardiovascular diseases. \n\nCardiovascular medicine has made great strides in recent decades. In the past ten years, myocardial infarction mortality has decreased by almost 50 percent. This development can be attributed to better medications for treating elevated cholesterol levels and fewer smokers. And yet, cardiovascular diseases remain at the top of the disease statistics. \n\nIn efforts to make further advances, patient-oriented, interdisciplinary research based on large-scale studies, cohorts and biobanks is becoming increasingly important. The German Centre for Cardiovascular Research (DZHK) has created a space for research projects of this kind. It provides a framework that allows researchers to work together to translate their research ideas into clinical practice better and faster than before. The main objective of the DZHK is to make new research results available to all patients in Germany as quickly as possible and to advance not only treatments but also diagnosis and prevention of cardiovascular diseases. \n\nIn cardiovascular research, a centre with a nationwide reach provides many advantages. This field has seen enormous progress in recent years; for this reason further progress is expected to be incremental rather than paradigmatic. To continue to make progress, ever larger multi-centre clinical studies, patient registries and biobanks will be needed. This can be implemented much better in one nationwide centre than in many small single institutions. This is why the DZHK brings together outstanding basic and clinical researchers from seven partner sites in Germany.
keywords:N/AN/A
Total Funding
59
Number of Employees
N/A
Revenue (est)
18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $13.3M | 59 | -21% | N/A |
#2 | $7.7M | 59 | N/A | N/A |
#3 | $13M | 59 | -18% | N/A |
#4 | $17.3M | 59 | 4% | N/A |
#5 | $13.3M | 59 | -21% | N/A |